Middleby CorpStockStory recommends avoiding Middleby due to flat earnings per share and diminishing returns on capital.
StockStory identifies Nasdaq as a cash-producing stock worth investigating while recommending investors avoid Middleby and U.S. Physical Therapy. Nasdaq, with a trailing 12-month free cash flow margin of 37%, posted 15% annual revenue growth over the past two years and earnings per share compounding at 14.8% annually, alongside an industry-leading 15.6% return on equity. Middleby, holding a 13.7% free cash flow margin, saw flat earnings per share and diminishing returns on capital, trading at $164.92 per share or 16.5 times forward earnings. U.S. Physical Therapy, with an 8.4% free cash flow margin on $795.5 million in revenue, experienced flat earnings per share over five years and shrinking returns on capital, trading at $66.39 per share or 22.1 times forward earnings.
Middleby CorpStockStory recommends avoiding Middleby due to flat earnings per share and diminishing returns on capital.
Nasdaq IncStockStory highlights Nasdaq as a cash-producing stock with strong free cash flow margin, revenue growth, and return on equity.
U.S. Physical Therapy, Inc.StockStory recommends avoiding U.S. Physical Therapy due to flat earnings per share and shrinking returns on capital.